Upregulation of c-Myc may contribute to the pathogenesis of canine pemphigus vulgaris

Veterinary Dermatology

Volumn 18, Issue 1, 2007, Pages 12-17

  Williamson, Lina ^a   Suter, Maja M ^a   Olivry, Thierry ^b   Wyder, Marianne ^a   Müller, Eliane J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE CONTROL STUDY; DOG; DOG DISEASE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; METABOLISM; MOUTH MUCOSA; PEMPHIGUS; SKIN; UPREGULATION;

ANIMALS; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MOUTH MUCOSA; PEMPHIGUS; PROTO-ONCOGENE PROTEINS C-MYC; SKIN; UP-REGULATION;

CANIS FAMILIARIS;

EID: 33845979160     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2007.00561.x     Document Type: Article

References (24)

1. Suter MM, de Bruin A, Wyder M et al. Autoimmune diseases of domestic animals: an update. Advances in Veterinary Dermatology 1998; 3: 321-37.
2. Stanley JR. Autoantibodies against adhesion molecules and structures in blistering skin diseases. Journal of Experimental Medicine 1995; 181: 1-4.
3. Nishifuji K, Amagai M, Ota T et al. Cloning of canine desmoglein 3 and immunoreactivity of serum antibodies in human and canine pemphigus vulgaris with its extracellular domains. Journal of Dermatological Science 2003; 32: 181-91.
4. Olivry T, Joubeh S, Dunston SM et al. Desmoglein-3 is a target autoantigen in spontaneous canine pemphigus vulgaris. Experimental Dermatology 2003; 12: 198-203.
5. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991; 67: 869-77.
6. Berkowitz P, Hu P, Liu Z et al. Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. Journal of Biological Chemistry 2005; 280: 23 778-84.
7. Sanchez-Carpintero I, Espana A, Pelacho B et al. In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades. British Journal of Dermatology 2004; 151: 565-70.
8. Williamson L, Raess NA, Caldelari R et al. Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO Journal 2006; 25: 3298-309.
9. Oskarsson T, Essers M, Dubois N et al. Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene. Genes and Development 2006; 20: 2024-9.
10. Tscharntke M, Pofahl R, Krieg T et al. Ras-induced spreading and wound closure in human epidermal keratinocytes. FASEB Journal 2005; 19: 1836-8.
11. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nature Review of Molecular and Cellular Biology 2005; 6: 635-45.
12. Arnold I, Watt FM. c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Current Biology 2001; 11: 558-68.
13. Waikel RL, Wang XJ, Roop DR. Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis. Oncogene 1999; 18: 4870-8.
14. Pelengaris S, Littlewood T, Khan M et al. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Molecular Cell 1999; 3: 565-77.
15. Wong P, Coulombe PA. Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. Journal of Cell Biology 2003; 163: 327-37.
16. Olivry T, LaVoy A, Dunston SM et al. Desmoglein-1 is a minor autoantigen in dogs with pemphigus foliaceus. Veterinary Immunology and Immunopathology 2006; 110: 245-55.
17. McGowan KM, Coulombe PA. Onset of keratin 17 expression coincides with the definition of major epithelial lineages during skin development. Journal of Cell Biology 1998; 143: 469-86.
18. Caldelari R, de Bruin A, Baumann D et al. A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. Journal of Cell Biology 2001; 153: 823-34.
19. Frye M, Gardner C, Li ER et al. Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment. Development 2003; 130: 2793-808.
20. Waikel RL, Kawachi Y, Waikel PA et al. Deregulated expression of c-Myc depletes epidermal stem cells. Nature Genetics 2001; 28: 165-8.
21. Chorzelski TP, Hashimoto T, Jablonska S et al. Pemphigus vulgaris transforming into pemphigus foliaceus and their coexistence. European Journal of Dermatology 1995; 5: 386-90.
22. Komai A, Amagai M, Ishii K et al. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay. British Journal of Dermatology 2001; 144: 1177-82.
23. Muller E, Kernland K, Caldelari R et al. Unusual pemphigus phenotype in the presence of a Dsg1 and Dsg3 autoantibody profile. Journal of Investigative Dermatology 2002; 118: 551-5.
24. Feliciani C, Motta A, Castellaneta M et al. Coexisting pemphigus vulgaris and pemphigus foliaceus in the same patient. International Journal of Dermatology 2005; 44: 139-41.